Clinical Trial Update: caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for caBozantinib in pre-treated metastatic colorectal cancer patients is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Refractory Colorectal Adenocarcinoma | Phase 2 | Status: UNKNOWN